O. Garbuzenko

发表

Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

T. Minko, Huixin He, O. Taratula, 2009, Biomacromolecules.

Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage.

Dennis E Discher, D. Discher, T. Minko, 2009, Molecular pharmaceutics.

Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

K. Reuhl, T. Minko, O. Garbuzenko, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.

T. Minko, C. M. Roth, O. Garbuzenko, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Metastatic and triple-negative breast cancer: challenges and treatment options

T. Minko, Sumayah Al-Mahmood, O. Garbuzenko, 2018, Drug Delivery and Translational Research.

Prevention of paclitaxel-induced neuropathy by formulation approach.

K. Deshpande, T. Minko, O. Garbuzenko, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.

T. Minko, O. Taratula, O. Garbuzenko, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers

T. Minko, O. Garbuzenko, A. Kuzmov, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Liposomal Form of Prostaglandin E 2 for Inhalation Treatment of Pulmonary Fibrosis

K. Reuhl, T. Minko, O. Garbuzenko, 2012 .

Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA

T. Minko, O. Taratula, Alex M. Chen, 2011, Journal of drug targeting.

Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy

T. Minko, O. Taratula, O. Garbuzenko, 2019, Theranostics.

Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer

D. Banerjee, J. Bertino, K. Scotto, 2018, Oncotarget.

Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis

A. Sigal, Y. Barenholz, H. Ovadia, 2009, Journal of Neuroimmunology.

Biodegradable Janus Nanoparticles for Local Pulmonary Delivery of Hydrophilic and Hydrophobic Molecules to the Lungs

T. Minko, M. Tomassone, O. Garbuzenko, 2014, Langmuir : the ACS journal of surfaces and colloids.

Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage

M. Zhang, S. Betigeri, T. Minko, 2010, Drug Delivery and Translational Research.

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

T. Minko, Huixin He, O. Taratula, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer

D. Banerjee, J. Bertino, K. Scotto, 2013, Cancer biology & therapy.

Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.

Y. Barenholz, O. Garbuzenko, A. Priev, 2005, Chemistry and physics of lipids.

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome.

Yechezkel Barenholz, Miklós Tóth, Y. Barenholz, 2012, Nanomedicine : nanotechnology, biology, and medicine.

Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug

T. Minko, O. Taratula, O. Garbuzenko, 2013, Clinical Cancer Research.

Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.

T. Minko, O. Taratula, Ronak Savla, 2013, Current drug discovery technologies.

Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy

Suzie Chen, T. Minko, Ronak Savla, 2014, Pharmaceutical Research.

Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention

G. Mainelis, T. Minko, O. Taratula, 2014, Cancer biology & medicine.

Cancer Therapy : Preclinical Targeted Nanomedicine for Suppression of CD 44 and Simultaneous Cell Death Induction in Ovarian Cancer : An Optimal Delivery of siRNA and Anticancer Drug

T. Minko, O. Taratula, O. Garbuzenko, 2013 .

Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.

T. Minko, O. Taratula, Ronak Savla, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

Huixin He, Ronak Savla, T. Minko, 2011, Current drug delivery.

Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug

Alexandre A. Vetcher, V. Soldatenkov, S. Betigeri, 2009, Pharmaceutical Research.

Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers.

Y. Barenholz, O. Garbuzenko, S. Zalipsky, 2005, Langmuir : the ACS journal of surfaces and colloids.

Metastatic and triple-negative breast cancer: challenges and treatment options

T. Minko, Sumayah Al-Mahmood, O. Garbuzenko, 2018, Drug Delivery and Translational Research.

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

T. Minko, O. Garbuzenko, Maha Saad, 2008, Nanomedicine.

Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases.

K. Reuhl, T. Minko, Min Zhang, 2012, Nanomedicine.

Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.

J. Kohn, T. Minko, O. Garbuzenko, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.

T. Minko, O. Garbuzenko, P. T. Yin, 2016, Biomaterials.

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance

Gediminas Mainelis, G. Mainelis, K. Reuhl, 2010, Proceedings of the National Academy of Sciences.

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

T. Minko, O. Garbuzenko, J. Khandare, 2008, Journal of controlled release : official journal of the Controlled Release Society.

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts

D. Banerjee, J. Bertino, K. Scotto, 2014, Oncotarget.

Multifunctional Nanotherapeutics for Cancer

V. Soldatenkov, A. Vetcher, T. Minko, 2008 .

Polymer Vesicles with a Red Cell-like Surface Charge: Microvascular Imaging and in vivo Tracking with Near-Infrared Fluorescence.

D. Discher, T. Minko, D. Christian, 2010, Macromolecular rapid communications.

Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.

G. Mainelis, T. Minko, O. Garbuzenko, 2013, Journal of aerosol medicine and pulmonary drug delivery.

Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin

J. Bertino, T. Minko, O. Garbuzenko, 2021, Cancers.

Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.

Bozena Michniak-Kohn, T. Minko, O. Garbuzenko, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).

K. Reuhl, T. Minko, O. Garbuzenko, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Nonviral Nanoscale-Based Delivery of Antisense Oligonucleotides Targeted to Hypoxia-Inducible Factor 1α Enhances the Efficacy of Chemotherapy in Drug-Resistant Tumor

Alexandre A. Vetcher, V. Soldatenkov, A. Vetcher, 2008, Clinical Cancer Research.

The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release.

Yechezkel Barenholz, Haim Ovadia, Y. Barenholz, 2007, Langmuir : the ACS journal of surfaces and colloids.

Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).

K. Reuhl, T. Minko, O. Garbuzenko, 2017, Nanomedicine : nanotechnology, biology, and medicine.